ARCHIVES

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO To Begin Large Study On Quality Of Cancer Care.

January 28, 2000

Letter to the Editors: Scientists, Media Shouldn’t Overstate “Breakthroughs”

May 29, 1998

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

Northwestern, Rochester, Howard First In Line For Limited Construction Funds

August 20, 1976

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012

GAO Calls For Stronger FDA Enforcement Of Accelerated Approval Followup Studies

October 30, 2009